Bristol-Myers Squibb Invests in Texas, Eli Lilly Succeeds in UK

Bristol-Myers Squibb (BMY) has committed $2.3 billion to investments in Texas, while Eli Lilly (LLY) has achieved significant success in the United Kingdom market.